Skip to content

Expanding HIV Testing Among Uganda Adults Who Utilize Traditional Healers

Expanding HIV Testing Among Uganda Adults Who Utilize Traditional Healers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03718871
Enrollment
500
Registered
2018-10-25
Start date
2017-07-01
Completion date
2020-08-01
Last updated
2021-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Behaviors, HIV/AIDS

Brief summary

HIV antiretroviral therapy has the potential to dramatically decrease HIV transmission worldwide1; yet, a barrier to ending the AIDS epidemic in low-resource settings is the fact that healthcare is largely provided by traditional or spiritual healers rather than biomedical providers, and there are no strategies in place to identify HIV-infected patients among Traditional Healer patients and link them to HIV care. In order to reach the UNAIDS 90-90-90 benchmarks HIV services must reach marginalized populations in endemic regions, such as in southwestern Uganda. Uganda is one of seven sub-Saharan African (SSA) countries accounting for 90% of all new HIV infections in this region6. HIV prevalence is 7.3%, with \ 1.5 million people living with HIV/AIDS and 99,000 new infections in 2014. However, only 50% of sexually active Ugandans have ever tested for HIV8. In the project location of southwestern Uganda, like much of SSA, the majority of Ugandans utilize Traditional Healers (TH), but little is known about Traditional Healer practices or rates of HIV testing (or HIV infection) among their clients. Specific aims of this study are to: 1) identify key socio-structural factors that frame HIV testing behaviors among Ugandan adults who utilize Traditional Healers; 2) investigate acceptability of providing point-of-care HIV testing at Traditional Healer practice locations; and 3) develop and pilot a prospective HIV testing intervention among Traditional Healer patients to promote earlier diagnosis. Results will be used to implement subsequent, large-scale cluster-randomized HIV testing intervention at Traditional Healer practice locations. Findings from the proposed study include formative data on populations that utilize Traditional Healers in an HIV-endemic region of Uganda, and pilot testing of an HIV testing intervention at healer practice locations; these results could be applied towards expanding HIV testing in other low-resource, endemic settings.

Detailed description

This study has three specific aims: Specific Aim 1: Identify key socio-structural factors that frame HIV testing behaviors among clients of Ugandan TH, using an exploratory sequential, mixed-methods study design. First, qualitative interviews with 25-35 purposely-sampled TH clients will characterize the care-seeking trajectory, HIV testing behaviors and related stigma, healthcare costs, and HIV risks and exposures. Based on these results, a survey will be designed and administered to 300 Ugandan adults who utilize TH in Mbarara District. This cross-sectional study will identify 1) rates of HIV testing among TH clients and 2) variables that independently predict HIV testing within the prior 12 months. These data will inform a model of HIV testing behavior among TH clients based on the Andersen Model of Healthcare Utilization, and generate hypotheses to be tested in Specific Aim 2. Specific Aim 2: Characterize acceptability of receiving point-of-care (POC) HIV testing at TH locations, using an exploratory sequential, mixed-methods approach. Qualitative interviews with 15-25 purposely sampled TH and 15-25 purposely-sampled TH clients will explore attitudes and experiences with biomedicine, feasibility and acceptability of delivering POC HIV testing at TH locations, and investigate relevant themes emerging from Aim 1. Based on qualitative results, a survey will be developed and administered to 175 TH in Mbarara District. This cross-sectional study will characterize TH practices relevant to HIV testing, and identify characteristics of healers who favorably view the proposed intervention (Specific Aim 3). These data will be integrated with results from SA1 to develop an intervention that will overcome socio-structural barriers to HIV testing. Specific Aim 3: Develop and pilot an HIV testing intervention among TH clients using a cluster randomized study design. Integration of results from SA1 and SA2 will inform a pilot HIV testing intervention at 9 TH practice locations, to be compared with a control group receiving usual TH care at 8 practices. This pilot will offer HIV testing at TH practice sites to 250 TH clients at the intervention arm sites, and offer protocoled usual care to 250 clients at control arm sites. Primary outcome for this study will be rates of HIV testing among TH clients. Secondary outcomes will include i) number of new HIV diagnoses among TH clients, and ii) number of patients with +HIV POC test who successfully link to HIV care in 3 months.

Interventions

BEHAVIORALHIV testing at traditional healer practices

HIV 1/2 antigen-antibody POC test (Oraquick©) will be administered to those participants who agree to test. Pre-test counseling will be performed before results are delivered. Clients with positive tests will be provided with detailed contact information for the MUST ISS clinic, and given specific instructions to present to the clinic as soon as possible for confirmatory testing and linkage to care.

Sponsors

Mbarara University of Science and Technology
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

This is a mixed methods study where Aims 1 and 2 have both qualitative and quantitative arms. Aim 3 is an unblinded intervention, with a control arm, to be delivered in cluster-randomized fashion (Sept 2019-June 2020). Healers will be treated as clusters and randomized to either intervention or control arm.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 year of age or older * able to provide informed consent * not known to be HIV infected * willing to be contacted at 3 months following enrollment * willing to complete an exit survey after 3 months

Exclusion criteria

* being under the age of 18 years * incapable of giving informed consent * previously being diagnosed with HIV * being unwilling to receive HIV test results * unwilling to participate in the testing intervention

Design outcomes

Primary

MeasureTime frameDescription
Number of TH Clients Who Received HIV Testingwithin 3 months following study visitPrimary study outcome was receipt of an HIV test within 90 days of enrollment. In the control arm, this was assessed via self-report at time of 90-day phone call follow up. For intervention arm, the participating healer recorded whether an HIV test was accepted by the participant at the time of the study visit. If the HIV test was accepted and delivered, the healer recorded the result of the test.

Secondary

MeasureTime frameDescription
Number of New HIV Diagnoses Among TH Clientswithin three months following enrollment.For intervention arm participants, the healer recorded the result of the point-of-care HIV test for those participants who agreed to test during the study visit. In the control arm, this outcomes was assessed via self-report during the 90-day follow up phone call.
Number of Patients With +HIV Test Who Successfully Link to HIV Careat three months following enrollment.This outcome was assessed via self-report during the 90-day follow up phone call. For participants newly testing HIV-positive, questions were posed to determine if they had received confirmatory testing, and initiated ART medication.
Age in Years of Control Arm Subjects Who Received an HIV Test3 months following study enrollmentParticipants in the control arm assessed for primary outcomes of receiving an HIV test within 3 months of study enrollment. Participant age in years at time of study enrollment, and association with primary outcome of receiving an HIV test
Gender of Control Arm Subjects Who Received an HIV Testat 3 months following enrollmentSelf-reported participant gender and association with primary study outcome of receiving an HIV test
Highest Level of Education for Control Arm Subjects Who Received an HIV Testat 3 months following study enrollmentParticipant self-reported highest level of education, and association with study primary outcome of receiving an HIV test

Countries

Uganda

Participant flow

Recruitment details

25 traditional healers practicing within an eight-kilometer distance from Mbarara Township were screened for eligibility.

Pre-assignment details

Five healers were excluded due to self-reported weekly volume \<7 patients. Three healers declined to participate because of scheduling conflicts. On August 2, 2019 the remaining 17 healers were randomized into two study arms (9 to intervention, 8 to control. From August 8, 2019-February 7, 2020, 500 participants were enrolled at healer cluster sites

Participants by arm

ArmCount
Healer Control Arm
Patients will undergo protcolized usual care at 8 healer practices, which include HIV education and a referral to receive VCT through local HIV testing clinics. Study staff will contact the client at 3 months following enrollment to assess for self-report of VCT.
250
Healer HIV Testing Intervention
HIV testing at traditional healer practices: HIV 1/2 antigen-antibody POC test (Oraquick©) will be administered to those participants who agree to test. Pre-test counseling will be performed before results are delivered.
250
Total500

Baseline characteristics

CharacteristicHealer HIV Testing InterventionTotalHealer Control Arm
Age, Continuous28.5 years29 years30 years
Number of participants who are Christian237 Participants455 Participants218 Participants
Number of participants who are married142 Participants306 Participants164 Participants
Number of participants who completed primary education or lower143 Participants282 Participants139 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
134 Participants279 Participants145 Participants
Sex: Female, Male
Male
116 Participants221 Participants105 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2500 / 250
other
Total, other adverse events
0 / 2500 / 250
serious
Total, serious adverse events
0 / 2500 / 250

Outcome results

Primary

Number of TH Clients Who Received HIV Testing

Primary study outcome was receipt of an HIV test within 90 days of enrollment. In the control arm, this was assessed via self-report at time of 90-day phone call follow up. For intervention arm, the participating healer recorded whether an HIV test was accepted by the participant at the time of the study visit. If the HIV test was accepted and delivered, the healer recorded the result of the test.

Time frame: within 3 months following study visit

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Healer Control ArmNumber of TH Clients Who Received HIV Testing57 Participants
Healer HIV Testing InterventionNumber of TH Clients Who Received HIV Testing250 Participants
Comparison: Given that the intervention arm showed 100% uptake, a multi-level regression model could not be created with a zero in the denominator in the intervention group. We therefore used Fisher's exact test to assess for significant differences in proportion of HIV testing between study arms.p-value: <0.00195% CI: [0.015, 0.363]Fisher Exact
Secondary

Age in Years of Control Arm Subjects Who Received an HIV Test

Participants in the control arm assessed for primary outcomes of receiving an HIV test within 3 months of study enrollment. Participant age in years at time of study enrollment, and association with primary outcome of receiving an HIV test

Time frame: 3 months following study enrollment

Population: Only control arm participants who received an HIV test were included in this analysis, as all intervention arm participants accepted an HIV test as part of the study and therefore, no other variates would be statistically associated with receiving a test more than being in the intervention study arm.

ArmMeasureValue (MEDIAN)
Healer Control ArmAge in Years of Control Arm Subjects Who Received an HIV Test30 years
Comparison: We considered variables that predicted the primary outcome of receiving an HIV test among control arm only, as uptake was 100% in the intervention. First we identified variables that were significant (two-sided p-value\<0.05) in univariate analysis and creating multivariate mixed-effects logistic regression model accounting for covariates and intercorrelation between participants from the same healer by including healers as random effects.p-value: <0.0195% CI: [1.02, 1.06]Regression, Linear
Secondary

Gender of Control Arm Subjects Who Received an HIV Test

Self-reported participant gender and association with primary study outcome of receiving an HIV test

Time frame: at 3 months following enrollment

Population: Participants in the control arm assessed for primary outcomes of receiving an HIV test within 3 months of study enrollment. Only control arm participants were included in this analysis, as all intervention arm participants accepted an HIV test as part of the study and therefore, no other variates would be statistically associated with receiving a test more than being in the intervention study arm.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Healer Control ArmGender of Control Arm Subjects Who Received an HIV TestMales17 Participants
Healer Control ArmGender of Control Arm Subjects Who Received an HIV TestFemales40 Participants
Comparison: We considered variables that predicted the primary outcome of receiving an HIV test among control arm only, as uptake was 100% in the intervention. First we identified variables that were significant (two-sided p-value\<0.05) in univariate analysis and creating multivariate mixed-effects logistic regression model accounting for covariates and intercorrelation between participants from the same healer by including healers as random effects.p-value: 0.0795% CI: [0.3, 1.04]Fisher Exact
Secondary

Highest Level of Education for Control Arm Subjects Who Received an HIV Test

Participant self-reported highest level of education, and association with study primary outcome of receiving an HIV test

Time frame: at 3 months following study enrollment

Population: We considered variables that predicted the primary outcome of receiving an HIV test among control arm only, as uptake was 100% in the intervention. First we identified variables that were significant (two-sided p-value\<0.05) in univariate analysis and creating multivariate mixed-effects logistic regression model accounting for covariates and intercorrelation between participants from the same healer by including healers as random effects.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Healer Control ArmHighest Level of Education for Control Arm Subjects Who Received an HIV TestPrimary school education or lower30 Participants
Healer Control ArmHighest Level of Education for Control Arm Subjects Who Received an HIV TestSecondary school education or higher27 Participants
Comparison: We considered variables that predicted the primary outcome of receiving an HIV test among control arm only, as uptake was 100% in the intervention. First we identified variables that were significant (two-sided p-value\<0.05) in univariate analysis and creating multivariate mixed-effects logistic regression model accounting for covariates and intercorrelation between participants from the same healer by including healers as random effects.p-value: 0.0995% CI: [0.16, 1.18]Fisher Exact
Secondary

Number of New HIV Diagnoses Among TH Clients

For intervention arm participants, the healer recorded the result of the point-of-care HIV test for those participants who agreed to test during the study visit. In the control arm, this outcomes was assessed via self-report during the 90-day follow up phone call.

Time frame: within three months following enrollment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Healer Control ArmNumber of New HIV Diagnoses Among TH Clients0 Participants
Healer HIV Testing InterventionNumber of New HIV Diagnoses Among TH Clients10 Participants
p-value: 0.002Fisher Exact
Secondary

Number of Patients With +HIV Test Who Successfully Link to HIV Care

This outcome was assessed via self-report during the 90-day follow up phone call. For participants newly testing HIV-positive, questions were posed to determine if they had received confirmatory testing, and initiated ART medication.

Time frame: at three months following enrollment.

Population: Zero participants in the control arm were newly diagnosed with HIV infection.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Healer Control ArmNumber of Patients With +HIV Test Who Successfully Link to HIV Care0 Participants
Healer HIV Testing InterventionNumber of Patients With +HIV Test Who Successfully Link to HIV Care7 Participants
p-value: 0.015Fisher Exact

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026